34Indexed trials
canonical disease area
Movement Disorders
Intelligence
Movement Disorders intelligence: 34 indexed trials, 8 recruiting studies, 33 sponsors across 20 countries.
8Recruiting
33Sponsors
20Countries
Leading sponsors
Icahn School of Medicine at Mount Sinai20 recruiting
Baylor College of Medicine10 recruiting
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental10 recruiting
Chelsea Therapeutics10 recruiting
Columbia University10 recruiting
Department of Medical Services Ministry of Public Health of Thailand10 recruiting
Biogen10 recruiting
Huashan Hospital10 recruiting
AbbVie10 recruiting
Institut National de la Santé Et de la Recherche Médicale, France10 recruiting
Ionis Pharmaceuticals, Inc.11 recruiting
AEON Biopharma, Inc.10 recruiting
Geographic activity
United States19trials
Canada4trials
Germany4trials
France4trials
Austria3trials
United Kingdom3trials
Spain3trials
Japan2trials
Iran1trials
Italy1trials
Australia1trials
New Zealand1trials
Leading interventions
Autologous Mesenchymal Stem Cells1trials
BIIB0921trials
BOTOX1trials
Bilateral 1 Hz Cerebellar rTMS1trials
Botulinum toxin type A1trials
Botulinum toxin, type B1trials
CX-89981trials
Cerebellar repetitive transcranial magnetic stimulation1trials
Change DBS programming1trials
Combination of metacognitive behavioral therapy and Neuro-physiotherapy1trials
Deep Brain Stimulation (DBS)1trials
ABP-4501trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.